Cleared Special

K200988 - Maximus System

K200988 is an FDA 510(k) clearance for Maximus System, manufactured by Hill-Rom Services Pte, Ltd.. The device is a Class 2 Anesthesiology device with product code NHJ cleared through the Special 510(k) pathway after a 41-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2020
Decision
41d
Days
Class 2
Risk

K200988 is an FDA 510(k) clearance for the Maximus System. Classified as Device, Positive Pressure Breathing, Intermittent (product code NHJ), Class II - Special Controls.

Submitted by Hill-Rom Services Pte, Ltd. (Singapore, SG). The FDA issued a Cleared decision on May 26, 2020 after a review of 41 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5905 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Hill-Rom Services Pte, Ltd. devices

FDA 510(k) Submission Details - K200988

510(k) Number K200988 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 15, 2020
Decision Date May 26, 2020
Days to Decision 41 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
99d faster than avg
Panel avg: 140d · This submission: 41d
Pathway characteristics
Modification to existing cleared device.

NHJ Device Classification - Class 2, Special Controls

Product Code NHJ Device, Positive Pressure Breathing, Intermittent
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5905
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - NHJ Device, Positive Pressure Breathing, Intermittent

All 11
Devices cleared under the same product code (NHJ) and FDA review panel - the closest regulatory comparables to K200988.
Clearo
K242438 · Breas Medical AB · May 2025
BiWaze Clear System
K231728 · Abmrc, LLC · Apr 2024
BiWaze Clear System
K213564 · Abmrc, LLC · Dec 2022
BiWaze Cough
K191912 · Abmrc, LLC · Mar 2020
Maximus System
K192143 · Hill-Rom Services Pte, Ltd. · Feb 2020
COUGHASSIST T70 DEVICE
K121955 · Respironics, Inc. · Dec 2012